Johnson & Johnson: Tobacco Use Disorder trials

The registry lists 21 Tobacco Use Disorder studies with Johnson & Johnson as lead sponsor. 0 are open to participants now and 6 have results posted.

Early Phase 1 1Phase 1 3Phase 3 2Phase 4 1No phase 14(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Study to Determine the Efficacy and Safety of a Novel Nicotine Replacement TherapyCompletedNCT02355665Phase 3Results posted
• Study to Determine if a New Nicotine Replacement Therapy Can Safely Help Smokers to Quit SmokingTerminatedNCT01296698Phase 3Results posted
• Bioequivalence Between Two New Oral Nicotine Replacement Therapy Products and Nicorette® MicrotabCompletedNCT01238640Not applicableResults posted
• Multiple-dose Nicotine Pharmacokinetics With a New Oral Nicotine Replacement Product.CompletedNCT01084707Not applicableResults posted
• Single-dose Nicotine Pharmacokinetics With a New Oral Nicotine Replacement ProductCompletedNCT01084603Not applicableResults posted
• Evaluation of the Safety Profile, Quit and Reduction Rate After Nicorette® Gum and Patch TreatmentCompletedNCT00749463Phase 4Results posted
• Clinical Study to Assess Bioequivalence Between Nicorette Extra Mint Gum and Nicorette® Mint Gum in Healthy SmokersCompletedNCT03259607Phase 1
• A Bioequivalence Study Between Two Nicotine Replacement Therapies in Adult Healthy Smokers Motivated to Quit.CompletedNCT03130179Phase 1
• An Exploratory Study Comparing Two Nicotine InhalersCompletedNCT01478230Early Phase 1
• A Study on the Effects of Two Nicotine Replacement Products on Tooth StainingCompletedNCT01440985Not applicable
• Nicotine Pharmacodynamics With a New Oral Nicotine Replacement Therapy and Nicotine GumCompletedNCT01368016Not applicable
• Multiple-dose Nicotine Pharmacokinetics With Three Oral Nicotine Replacement ProductsCompletedNCT01321931Phase 1
• Bioequivalence Between Two Oral Nicotine Sublingual Tablets, 2 mg and 4 mgCompletedNCT01238627Not applicable
• Single-dose Nicotine Pharmacokinetics With Four Oral Nicotine Replacement ProductsCompletedNCT01234896Not applicable
• Single-dose Nicotine Pharmacokinetics With Three Oral Nicotine Replacement Products. A Study in Healthy Smokers.CompletedNCT01234792Not applicable
• Single-dose Pharmacokinetics of Oral Nicotine Replacement ProductsCompletedNCT01228617Not applicable
• Comparative Pharmacokinetic Study of New Oral Nicotine Replacement Therapy Products.CompletedNCT01227720Not applicable
• Bioequivalence Between an Oral Nicotine Replacement Product and Nicorette® GumCompletedNCT01152749Not applicable
• Pharmacokinetics With a New Oral Nicotine Replacement Product and Nicorette® GumCompletedNCT01152736Not applicable
• Pharmacokinetics With Two New Oral Nicotine Replacement Products and Nicorette® GumCompletedNCT01152723Not applicable
• Bioequivalence Between Nicotine Replacement Products and Nicorette® GumCompletedNCT01113424Not applicable